Launched in 2015 with a focus on conducting strategic clinical trials with high accuracy and streamlined efficiency. Broad Street helps medical technology pioneers achieve success by accruing relevant clinical data for both regulatory approval and product improvement. Clients include companies ranging from start-ups to Fortune 500 corporations. Based centrally in the Minneapolis-St Paul, Minnesota area, Broad Street works with clients from coast to coast and in Europe; remote collaborations are as seamless as face-to-face. Therapeutic areas span cardiology, neurology, urology, oncology, pulmonology, infectious disease, obesity, and others. Technologies include imaging modalities, implants, therapeutic catheters, hemostatic agents, and more.
Every breakthrough biotechnology is unique and poised to improve patient outcomes; the clinical studies evaluating the technology should be customized to highlight its capabilities while also serving the company's business needs. Broad Street understands the priorities for clinical research from First in Human Pilot Studies to Pivotal Regulatory Trials to Post-Market Surveillance. Designing and conducting strategic and efficient clinical trials results in a quick path to regulatory approval and a successful entry into the competitive global marketplace. Broad Street helps plan and conduct every aspect of clinical research from protocol design to final results report and publication.
Broad Street can assist in planning and launching a new study or stepping in to manage an ongoing and evolving study. We leverage best practices in clinical research while adhering to all applicable regulations, to customize a plan for your innovative technology. Services include these and more.